DefiantVC

Value Proposition & Features

Rivia is a Zurich-based clinical-trial intelligence company that consolidates data from disparate systems into a unified intelligence layer, helping biotech teams analyze patient safety, efficacy, and operational data in real time. [E1] Its stated goal is more predictable operations and faster, more efficient trial execution. [E1]
  • Unified trial-data engine: Aggregates data across vendors and systems into one intelligence layer. [E1]
  • Automated data-quality monitoring: Checks and monitors clinical-trial data quality automatically. [7m313m]
  • Real-time analysis: Supports analysis of safety, efficacy, and operational data during trial execution. [7m313m]
  • Scientific logic layer: Applies scientific logic to unified data. [i6guf2]
  • AI-agent workflows: Embeds AI agents into review workflows. [i6guf2]
  • Operational intelligence: Aims to make clinical-trial operations more predictable. [E1]
  • Faster trial execution: Positions the platform as a way to improve trial efficiency. [E1]

Screenshots

No three official public screenshots were identified in the available sources.

Product Roadmap / Announcements

As of March 10, 2026, no reliable public roadmap or product announcement from the preceding six months was identified in the available sources.

Recent Developments

  • Rivia was reported as having raised a $15 million Series A in March 2026. [i6guf2]

History and Origin Story

Rivia was founded in 2022 and is headquartered in Zurich, Switzerland. [E1] Publicly available material describes its origin around the problem of clinical-trial data being fragmented across vendors, with the company building a unified intelligence layer to support real-time trial analysis and more predictable execution. [E1]

Fundraising History

Round Date Amount Lead investor
Seed June 12, 2024 $3.2M No reliable source found
Series A March 1, 2026 $15.0M No reliable source found
Total — $18.2M reported —
[E1] [i6guf2]

Market Sizing

Category, Market Size, and Category Growth

Rivia appears to operate in the clinical-trial data management, clinical-trial intelligence, and healthcare AI software categories. Its product combines data integration, automated quality monitoring, scientific logic, and AI-assisted review workflows. [7m313m] [i6guf2]

Competitive Landscape

Who it's for, who it's not for

Rivia is aimed at biotech and pharmaceutical teams that manage multi-vendor clinical-trial data and need real-time visibility into safety, efficacy, data quality, and trial operations. [7m313m] [E1]
It is not evidently aimed at patients, general-purpose analytics users, or organizations seeking a consumer health application; available descriptions focus specifically on clinical-trial intelligence and operational workflows. [7m313m] [i6guf2]

Viable Alternatives

  • QuantHealth: AI-driven clinical-trial design and simulation software for pharmaceutical and biotech companies. [la771d]
  • Cori Clinical: AI workspace connecting protocol design, trial knowledge, regulatory guidance, budgets, and operational assumptions. [u80xmz] [k874pj]
  • Biorce / Aika: AI platform built around a large clinical-trial dataset and focused on reducing protocol amendments. [u80xmz]
  • Unlearn: Develops digital twins of trial participants for drug development. [e8saxj]
  • Virtonomy: Creates synthetic patient populations for medical-device development. [e8saxj]

Competitor Table

Competitor Description
QuantHealth AI-powered clinical-trial design and simulation platform for pharma and biotech.
Cori Clinical AI workspace for clinical-trial design and execution decisions.
Biorce / Aika Clinical-trial AI platform using a large historical trial dataset to help limit protocol amendments.
Unlearn Digital-twin technology for drug-development trials.
Virtonomy Synthetic-population and virtual-patient technology for medical-device development.
Sources for Table: [la771d] [u80xmz] [k874pj] [e8saxj]

Sources

[7m313m] 2026, Oct 09. startupticker.ch . Swiss companies prepare to take center stage at Bio Europe . Updated: 2026, Oct 30. Generated: 2026, Nov 02. Perplexity API response.

[i6guf2] 2026, Oct 12. ventureradar.com . New Funding Rounds in "agentic data" - VentureRadar . Updated: 2026, Oct 28. Generated: 2026, Nov 02. Perplexity API response.

[u80xmz] 2026, Oct 07. techfundingnews.com . London startup Cori Clinical raises $4M to cut the cost of ... . Updated: 2026, Nov 02. Generated: 2026, Nov 02. Perplexity API response. [4]: 2026, Oct 28. newsdigestai.com . Partnerships & Deals AI News | News Digest AI . Updated: 2026, Oct 29. Generated: 2026, Nov 02. Perplexity API response. [5]: 2026, Oct 27. finance.yahoo.com . Swiss AI drug trial start-up receives funding from Spotify ... . Updated: 2026, Nov 01. Generated: 2026, Nov 02. Perplexity API response. [6]: 2026, Oct 11. clinicaltrialvanguard.com . Advarra funds PRIM&R AI ethics curriculum for research oversight . Updated: 2026, Nov 01. Generated: 2026, Nov 02. Perplexity API response. [7]: 2026, Oct 30. thebench.bio . Biotech funding news . Updated: 2026, Nov 02. Generated: 2026, Nov 02. Perplexity API response.

[e8saxj] 2026, Oct 26. techfundingnews.com . Leeds spinout adsilico lands £10M Series A to fix medtech’s ... . Updated: 2026, Nov 02. Generated: 2026, Nov 02. Perplexity API response.

[k874pj] 2026, Oct 07. techstartups.com . Startup Funding News Today, October 7, 2026: Nous Research ... . Updated: 2026, Nov 02. Generated: 2026, Nov 02. Perplexity API response.

Sources (retrieved)

[E1] rivia.com . Rivia . Generated: 2026, Nov 02. Exa.ai API response.